Abstract
The chapter is focused on the mechanism of action of metabotropic P2Y nucleotide receptors: P2Y1, P2Y2, P2Y12, P2Y14 and the ionotropic P2X7 receptor in glioma C6 cells. P2Y1 and P2Y12 both respond to ADP, but while P2Y1 links to PLC and elevates cytosolic Ca2+ concentration, P2Y12 negatively couples to adenylate cyclase, maintaining cAMP at low level. In glioma C6, these two P2Y receptors modulate activities of ERK1/2 and PI3K/Akt signaling and the effects depend on physiological conditions of the cells. During prolonged serum deprivation, cell growth is arrested, the expression of the P2Y1 receptor strongly decreases and P2Y12 becomes a major player responsible for ADP-evoked signal transduction. The P2Y12 receptor activates ERK1/2 kinase phosphorylation (a known cell proliferation regulator) and stimulates Akt activity, contributing to glioma invasiveness. In contrast, P2Y1 has an inhibitory effect on Akt pathway signaling. Furthermore, the P2X7 receptor, often responsible for apoptotic fate, is not involved in Ca2+elevation in C6 cells. The shift in nucleotide receptor expression from P2Y1 to P2Y12 during serum withdrawal, the cross talk between both receptors and the lack of P2X7 activity shows the precise self-regulating mechanism, enhancing survival and preserving the neoplastic features of C6 cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Akt:
-
protein kinase B/Akt kinase
- Ap4A:
-
p1,p4-Di(adenosine-5âČ)tetraphosphate
- BzATP:
-
2â,3âČ- 0-(4-benzoylbenzoyl)-ATP
- [Ca2+]i :
-
intracellular calcium concentration
- DAG:
-
diacylglycerol
- ER:
-
endoplasmic reticulum
- ERK1/2:
-
extracellular signal-regulated kinases 1/2.
- Gap1:
-
GTP-ase activating protein 1
- GBM:
-
glioblastoma multiforme
- GEF:
-
guanine nucleotide exchange factor
- GFAP:
-
glial fibrillary acidic protein
- GFP:
-
green fluorescent protein
- GPCRG:
-
protein-coupled receptor
- IP3 :
-
inositol-1,4,5-trisphosphate
- LPS:
-
lipopolysacharide
- MEK:
-
MAP kinase-ERK kinase
- 2MeSADP:
-
2-methylthio ADP
- OxATP:
-
periodate-oxidized ATP
- PDK1:
-
phosphoinositide-dependent protein kinase 1.
- PI3K:
-
phosphatidylinositol 3-kinase
- PIP2 :
-
phosphatidylinositol-4,5-bisphosphate
- PKA:
-
protein kinase A
- PKC:
-
protein kinase C
- PLC:
-
phospholipase C
- PPADS:
-
pyridoxal-phosphate-6-azophenyl-2âČ,4âdisulfonic acid
- PTEN:
-
phosphatase and tensin homolog
- PTX:
-
pertussis toxin
- RTK:
-
receptor tyrosine kinase
References
Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445â475
Abbracchio MP, Verderio C (2006) Pathophysiological roles of P2 receptors in glial cells. Novartis Found Symp 276:91â103; discussion 103-112, 275-181
Abbracchio MP, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Miras-Portugal MT, King BF, Gachet C, Jacobson KA, Weisman GA, Burnstock G (2003) Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24:52â55. https://doi.org/10.1016/S0165-6147(02)00038-X
Aerts I, Grobben B, Van Ostade X, Slegers H (2011) Cyclic AMP-dependent down regulation of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) in rat C6 glioma. Eur J Pharmacol 654:1â9. https://doi.org/10.1016/j.ejphar.2010.11.031
Anderson CM, Nedergaard M (2006) Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons. Trends Neurosci 29:257â262. https://doi.org/10.1016/j.tins.2006.03.003
Arslan G, Fredholm BB (2000) Stimulatory and inhibitory effects of adenosine a(2A) receptors on nerve growth factor-induced phosphorylation of extracellular regulated kinases 1/2 in PC12 cells. Neurosci Lett 292:183â186
Auer RN, Del Maestro RF, Anderson R (1981) A simple and reproducible experimental in vivo glioma model. Can J Neurol Sci 8:325â331
Bagchi S, Liao Z, Gonzalez FA, Chorna NE, Seye CI, Weisman GA, Erb L (2005) The P2Y2 nucleotide receptor interacts with alphav integrins to activate go and induce cell migration. J Biol Chem 280:39050â39057. https://doi.org/10.1074/jbc.M504819200
Banachewicz W, SupĆat D, KrzemiĆski P, Pomorski P, BaraĆska J (2005) P2 nucleotide receptors on C2C12 satellite cells. Purinergic Signal 1:249â257. https://doi.org/10.1007/s11302-005-6311-0
BaraĆska J, Chaban V, Czarny M, SabaĆa P (1995) Changes in Ca2+ concentration in phorbol ester and thapsigargin treated glioma C6 cells. The role of protein kinase C in regulation of Ca2+ entry. Cell Calcium 17:207â215
BaraĆska J, Czajkowski R, SabaĆa P (2004) Cross-talks between nucleotide receptor-induced signaling pathways in serum-deprived and non-starved glioma C6 cells. Adv Enzym Regul 44:219â232. https://doi.org/10.1016/j.advenzreg.2003.11.001
BaraĆska J, Czajkowski R, Pomorski P (2017) P2Y1 receptors â properties and functional activities. Adv Exp Med Biol â Protein Rev 19:71â89. https://doi.org/10.1007/5584_2017_57
Barth RF (1998) Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neuro-Oncol 36:91â102
Benda P, Lightbody J, Sato G, Levine L, Sweet W (1968) Differentiated rat glial cell strain in tissue culture. Science 161:370â371
Berridge MJ (1995) Capacitative calcium entry. Biochem J 312(Pt 1):1â11
Bezzi P, Volterra A (2001) A neuron-glia signalling network in the active brain. Curr Opin Neurobiol 11:387â394
Bianco F, Fumagalli M, Pravettoni E, DâAmbrosi N, Volonte C, Matteoli M, Abbracchio MP, Verderio C (2005) Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia. Brain Res Brain Res Rev 48:144â156. https://doi.org/10.1016/j.brainresrev.2004.12.004
Bianco F, Ceruti S, Colombo A, Fumagalli M, Ferrari D, Pizzirani C, Matteoli M, Di Virgilio F, Abbracchio MP, Verderio C (2006) A role for P2X7 in microglial proliferation. J Neurochem 99:745â758. https://doi.org/10.1111/j.1471-4159.2006.04101.x
Bianco F, Colombo A, Saglietti L, Lecca D, Abbracchio MP, Matteoli M, Verderio C (2009) Different properties of P2X(7) receptor in hippocampal and cortical astrocytes. Purinergic Signal 5:233â240. https://doi.org/10.1007/s11302-009-9137-3
Boarder MR, Hourani SM (1998) The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci 19:99â107
Boarder M, Webb TE (2001) P2Y receptors: structure and function. In: Abbracchio MP, Williams M (eds) Purinergic and pirimidinergic signalling. Springer, Berlin
Bos JL (2003) Epac: a new cAMP target and new avenues in cAMP research. Nat Rev Mol Cell Biol 4:733â738. https://doi.org/10.1038/nrm1197
Boyer JL, Lazarowski ER, Chen XH, Harden TK (1993) Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase. J Pharmacol Exp Ther 267:1140â1146
Braganhol E, Huppes D, Bernardi A, Wink MR, Lenz G, Battastini AM (2009) A comparative study of ectonucleotidase and P2 receptor mRNA profiles in C6 cell line cultures and C6 ex vivo glioma model. Cell Tissue Res 335:331â340. https://doi.org/10.1007/s00441-008-0723-4
Brazil DP, Hemmings BA (2001) Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26:657â664
Brismar T (1995) Physiology of transformed glial cells. Glia 15:231â243
Burnstock G (1997) The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36:1127â1139
Burnstock G (2002) Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin Med 2:45â53
Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659â797. https://doi.org/10.1152/physrev.00043.2006
Burnstock G (2015) Intracellular expression of purinoceptors. Purinergic Signal 11:275â276. https://doi.org/10.1007/s11302-015-9455-6
Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 96:4240â4245
Carrasquero LM, Delicado EG, Jimenez AI, Perez-Sen R, Miras-Portugal MT (2005) Cerebellar astrocytes co-express several ADP receptors. Presence of functional P2Y(13)-like receptors. Purinergic Signal 1:153â159. https://doi.org/10.1007/s11302-005-6211-3
Carrasquero LM, Delicado EG, Bustillo D, Gutierrez-Martin Y, Artalejo AR, Miras-Portugal MT (2009) P2X7 and P2Y13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes. J Neurochem 110:879â889. https://doi.org/10.1111/j.1471-4159.2009.06179.x
Carter RL, Fricks IP, Barrett MO, Burianek LE, Zhou Y, Ko H, Das A, Jacobson KA, Lazarowski ER, Harden TK (2009) Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor. Mol Pharmacol 76:1341â1348. https://doi.org/10.1124/mol.109.058578
Chen L, Brosnan CF (2006) Regulation of immune response by P2X7 receptor. Crit Rev Immunol 26:499â513
Cheng X, Ji Z, Tsalkova T, Mei F (2008) Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin Shanghai 40:651â662
Chiono M, Mahey R, Tate G, Cooper DM (1995) Capacitative Ca2+ entry exclusively inhibits cAMP synthesis in C6-2B glioma cells. Evidence that physiologically evoked Ca2+ entry regulates Ca(2+)-inhibitable adenylyl cyclase in non-excitable cells. J Biol Chem 270:1149â1155
Chou RC, Langan TJ (2003) In vitro synchronization of mammalian astrocytic cultures by serum deprivation. Brain Res Brain Res Protoc 11:162â167
Claes P, Grobben B, Van Kolen K, Roymans D, Slegers H (2001) P2Y(AC)(â)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase. Br J Pharmacol 134:402â408. https://doi.org/10.1038/sj.bjp.0704271
Claes P, Van Kolen K, Roymans D, Blero D, Vissenberg K, Erneux C, Verbelen JP, Esmans EL, Slegers H (2004) Reactive blue 2 inhibition of cyclic AMP-dependent differentiation of rat C6 glioma cells by purinergic receptor-independent inactivation of phosphatidylinositol 3-kinase. Biochem Pharmacol 67:1489â1498. https://doi.org/10.1016/j.bcp.2003.12.017
Collins VP (1998) Gliomas. Cancer Surv 32:37â51
Communi D, Govaerts C, Parmentier M, Boeynaems JM (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272:31969â31973
Communi D, Gonzalez NS, Detheux M, Brezillon S, Lannoy V, Parmentier M, Boeynaems JM (2001) Identification of a novel human ADP receptor coupled to G(i). J Biol Chem 276:41479â41485. https://doi.org/10.1074/jbc.M105912200
Czajkowski R, BaraĆska J (2002) Cross-talk between the ATP and ADP nucleotide receptor signalling pathways in glioma C6 cells. Acta Biochim Pol 49:877â889
Czajkowski R, Lei L, SabaĆa P, BaraĆska J (2002) ADP-evoked phospholipase C stimulation and adenylyl cyclase inhibition in glioma C6 cells occur through two distinct nucleotide receptors, P2Y(1) and P2Y(12). FEBS Lett 513:179â183
Czajkowski R, Banachewicz W, Ilnytska O, Drobot LB, BaraĆska J (2004) Differential effects of P2Y1 and P2Y12 nucleotide receptors on ERK1/ERK2 and phosphatidylinositol 3-kinase signalling and cell proliferation in serum-deprived and nonstarved glioma C6 cells. Br J Pharmacol 141:497â507. https://doi.org/10.1038/sj.bjp.0705639
Dahl D (1981) The vimentin-GFA protein transition in rat neuroglia cytoskeleton occurs at the time of myelination. J Neurosci Res 6:741â748. https://doi.org/10.1002/jnr.490060608
de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474â477. https://doi.org/10.1038/24884
De Vuyst E, Decrock E, De Bock M, Yamasaki H, Naus CC, Evans WH, Leybaert L (2007) Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor. Mol Biol Cell 18:34â46. https://doi.org/10.1091/mbc.e06-03-0182
Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587â600
Di Virgilio F, Ben DD, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflamation. Immunity 47:15â31. https://doi.org/10.1016/j.immuni.2017.06.0200
Di Virgilio F, Guiliani AL, Vultagio-Poma V, Falzoni S, Alba CS (2018) Non-nucleotide agonists triggering P2X7 receptor activation and pore formation. Front Pharmacol 9:1â10. https://doi.org/10.3389/fphar.2018.00039
Duan S, Anderson CM, Keung EC, Chen Y, Swanson RA (2003) P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J Neurosci 23:1320â1328
Dugan LL, Kim JS, Zhang Y, Bart RD, Sun Y, Holtzman DM, Gutmann DH (1999) Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J Biol Chem 274:25842â25848
Erb L, Weisman GA (2012) Coupling of P2Y receptors to G proteins and other signaling pathways. WIREs Membr Transport Signal 1:789â803. https://doi.org/10.1002/wmts.62
Erb L, Liu J, Ockerhausen J, Kong Q, Garrad RC, Griffin K, Neal C, Krugh B, Santiago-Perez LI, Gonzalez FA, Gresham HD, Turner JT, Weisman GA (2001) An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transduction. J Cell Biol 153:491â501
Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Collo G, Buell G, Di Virgilio F (1997) ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36:1295â1301
Fischer W, Appelt K, Grohmann M, Franke H, Norenberg W, Illes P (2009) Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat. Neuroscience 160:767â783. https://doi.org/10.1016/j.neuroscience.2009.02.026
Fricks IP, Maddileti S, Carter RL, Lazarowski ER, Nicholas RA, Jacobson KA, Harden TK (2008) UDP is a competitive antagonist at the human P2Y14 receptor. J Pharmacol Exp Ther 325:588â594. https://doi.org/10.1124/jpet.108.136309
Fricks IP, Carter RL, Lazarowski ER, Harden TK (2009) Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems. J Pharmacol Exp Ther 330:162â168. https://doi.org/10.1124/jpet.109.150730
Fumagalli M, Brambilla R, DâAmbrosi N, Volonte C, Mateoli M, Verderio C, Abbracchio MP (2003) Nucleotide-mediated calcium signaling in rat cortical astrocytes: role of P2X and P2Y receptors. Glia 43:218â230
Fumagalli M, Trincavelli L, Lecca D, Martini C, Ciana P, Abbracchio MP (2004) Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor. Biochem Pharmacol 68:113â124. https://doi.org/10.1016/j.bcp.2004.02.038
Furnari FB, Huang HJ, Cavenee WK (1998) The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 58:5002â5008
Gachet C (2006) Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 46:277â300. https://doi.org/10.1146/annurev.pharmtox.46.120604.141207
Grobben B, Claes P, Van Kolen K, Roymans D, Fransen P, Sys SU, Slegers H (2001) Agonists of the P2Y(AC)-receptor activate MAP kinase by a ras-independent pathway in rat C6 glioma. J Neurochem 78:1325â1338
Grobben B, De Deyn PP, Slegers H (2002) Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310:257â270. https://doi.org/10.1007/s00441-002-0651-7
Guo LH, Trautmann K, Schluesener HJ (2004) Expression of P2X4 receptor in rat C6 glioma by tumor-associated macrophages and activated microglia. J Neuroimmunol 152:67â72. https://doi.org/10.1016/j.jneuroim.2004.04.005
Hanson MG Jr, Shen S, Wiemelt AP, McMorris FA, Barres BA (1998) Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J Neurosci 18:7361â7371
Harden K, Barnard EA, Boeynaems JM, Burnstock G, Dubyak G, Hourani SM, Insel PA (1998) P2Y receptors. In: Girdlestone D (ed) The IUPHAR compendium of receptor characterization and classification, 2nd edn. IUPHAR Media Ltd, London
Harden TK, Sesma JI, Fricks IP, Lazarowski ER (2010) Signalling and pharmacological properties of the P2Y14 receptor. Acta Physiol (Oxf) 199:149â160. https://doi.org/10.1111/j.1748-1716.2010.02116.x
Hirano Y, Okajima F, Tomura H, Majid MA, Takeuchi T, Kondo Y (1991) Change of intracellular calcium of neural cells induced by extracellular ATP. FEBS Lett 284:235â237
Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202â207. https://doi.org/10.1038/35051599
Illes P, Alexandre Ribeiro J (2004) Molecular physiology of P2 receptors in the central nervous system. Eur J Pharmacol 483:5â17
Ito A, Satoh T, Kaziro Y, Itoh H (1995) G protein beta gamma subunit activates Ras, Raf, and MAP kinase in HEK 293 cells. FEBS Lett 368:183â187
Jalink K, Hordijk PL, Moolenaar WH (1994) Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim Biophys Acta 1198:185â196
Jin J, Tomlinson W, Kirk IP, Kim YB, Humphries RG, Kunapuli SP (2001) The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor. Br J Pharmacol 133:521â528. https://doi.org/10.1038/sj.bjp.0704114
Kim S, Jee K, Kim D, Koh H, Chung J (2001) Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1. J Biol Chem 276:12864â12870. https://doi.org/10.1074/jbc.M001492200
Kim SG, Gao ZG, Soltysiak KA, Chang TS, Brodie C, Jacobson KA (2003) P2Y6 nucleotide receptor activates PKC to protect 1321N1 astrocytoma cells against tumor necrosis factor-induced apoptosis. Cell Mol Neurobiol 23:401â418
King BF, Burnstock G, Boyer JL, Boeynaems J-M, Weisman GA, Kennedy C, Jacobson KA, Humphries RG, Abbracchio MP, Miras-Portugal MT (2000) The P2Y receptors. In: Girdlestone D (ed) The IUPHAR compendium of receptor characterization and classification, 2nd edn. IUPHAR Media Ltd., London
Kitanaka J, Hashimoto H, Gotoh M, Mayumi T, Baba A (1992) Mechanism of extracellular ATP-stimulated phosphoinositide hydrolysis in rat glioma C6 cells. J Pharmacol Exp Ther 263:1248â1252
Kopperud R, Krakstad C, Selheim F, Doskeland SO (2003) cAMP effector mechanisms. Novel twists for an âoldâ signaling system. FEBS Lett 546:121â126
Koschel K, Tas PW (1993) Lysophosphatidic acid reverts the beta-adrenergic agonist-induced morphological response in C6 rat glioma cells. Exp Cell Res 206:162â166
Kranenburg O, Moolenaar WH (2001) Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene 20:1540â1546. https://doi.org/10.1038/sj.onc.1204187
KrzemiĆski P, SupĆat D, Czajkowski R, Pomorski P, BaraĆska J (2007) Expression and functional characterization of P2Y1 and P2Y12 nucleotide receptors in long-term serum-deprived glioma C6 cells. FEBS J 274:1970â1982. https://doi.org/10.1111/j.1742-4658.2007.05741.x
KrzemiĆski P, Pomorski P, BaraĆska J (2008) The P2Y14 receptor activity in glioma C6 cells. Eur J Pharmacol 594:49â54. https://doi.org/10.1016/j.ejphar.2008.06.092
Kubiatowski T, Jang T, Lachyankar MB, Salmonsen R, Nabi RR, Quesenberry PJ, Litofsky NS, Ross AH, Recht LD (2001) Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J Neurosurg 95:480â488. https://doi.org/10.3171/jns.2001.95.3.0480
Kurino M, Fukunaga K, Ushio Y, Miyamoto E (1996) Cyclic AMP inhibits activation of mitogen-activated protein kinase and cell proliferation in response to growth factors in cultured rat cortical astrocytes. J Neurochem 67:2246â2255
Lazarowski E (2006) Regulated release of nucleotides and UDP sugars from astrocytoma cells. Novartis Found Symp 276:73â84; discussion 84-90, 107-112, 275-181
Leon C, Hechler B, Vial C, Leray C, Cazenave JP, Gachet C (1997) The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 403:26â30
Liao Z, Seye CI, Weisman GA, Erb L (2007) The P2Y2 nucleotide receptor requires interaction with alpha v integrins to access and activate G12. J Cell Sci 120:1654â1662. https://doi.org/10.1242/jcs.03441
Lin WW, Chuang DM (1993) Extracellular ATP stimulates inositol phospholipid turnover and calcium influx in C6 glioma cells. Neurochem Res 18:681â687
Lin WW, Chuang DM (1994) Different signal transduction pathways are coupled to the nucleotide receptor and the P2Y receptor in C6 glioma cells. J Pharmacol Exp Ther 269:926â931
Locovei S, Scemes E, Qiu F, Spray DC, Dahl G (2007) Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett 581:483â488. https://doi.org/10.1016/j.febslet.2006.12.056
McKenzie FR, Pouyssegur J (1996) cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases. J Biol Chem 271:13476â13483
Messens J, Slegers H (1992) Synthesis of glial fibrillary acidic protein in rat C6 glioma in chemically defined medium: cyclic AMP-dependent transcriptional and translational regulation. J Neurochem 58:2071â2080
Moolenaar WH (1999) Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res 253:230â238. https://doi.org/10.1006/excr.1999.4702
Moore DJ, Murdock PR, Watson JM, Faull RL, Waldvogel HJ, Szekeres PG, Wilson S, Freeman KB, Emson PC (2003) GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. Brain Res Mol Brain Res 118:10â23
Neary JT, Zimmermann H (2009) Trophic functions of nucleotides in the central nervous system. Trends Neurosci 32:189â198. https://doi.org/10.1016/j.tins.2009.01.002
Nicholas RA, Watt WC, Lazarowski ER, Li Q, Harden K (1996) Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol Pharmacol 50:224â229
North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013â1067. https://doi.org/10.1152/physrev.00015.2002
North RA, Surprenant A (2000) Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563â580. https://doi.org/10.1146/annurev.pharmtox.40.1.563
Oey J (1975) Noradrealine induces morphological alterations in nucleated and enucleated rat C6 glioma cells. Nature 257:317â319
Pelegrin P, Surprenant A (2006) Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25:5071â5082. https://doi.org/10.1038/sj.emboj.7601378
Putney JW Jr, Bird GS (1993) The inositol phosphate-calcium signaling system in nonexcitable cells. Endocr Rev 14:610â631. https://doi.org/10.1210/edrv-14-5-610
Qiu W, Zhuang S, von Lintig FC, Boss GR, Pilz RB (2000) Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins. J Biol Chem 275:31921â31929. https://doi.org/10.1074/jbc.M003327200
Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413â492
Roymans D, Grobben B, Claes P, Slegers H (2001) Protein tyrosine kinase-dependent regulation of adenylate cyclase and phosphatidylinositol 3-kinase activates the expression of glial fibrillary acidic protein upon induction of differentiation in rat c6 glioma. Cell Biol Int 25:467â474. https://doi.org/10.1006/cbir.2000.0636
Ryten M, Dunn PM, Neary JT, Burnstock G (2002) ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells. J Cell Biol 158:345â355. https://doi.org/10.1083/jcb.200202025
Ryu JK, Jantaratnotai N, Serrano-Perez MC, McGeer PL, McLarnon JG (2011) Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model. J Neuropathol Exp Neurol 70:13â22. https://doi.org/10.1097/NEN.0b013e318201d4d4
SabaĆa P, Czajkowski R, PrzybyĆek K, Kalita K, Kaczmarek L, BaraĆska J (2001) Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells. Br J Pharmacol 132:393â402. https://doi.org/10.1038/sj.bjp.0703843
Sak K, Illes P (2005) Neuronal and glial cell lines as model systems for studying P2Y receptor pharmacology. Neurochem Int 47:401â412. https://doi.org/10.1016/j.neuint.2005.05.012
Salcman M (1995) Glioblastoma and malignant astrocytoma. In: Kaye AH, Laws ER (eds) Brain tumors: an encyclopedic approach. Churchill Livingstone, New York
Savi P, Labouret C, Delesque N, Guette F, Lupker J, Herbert JM (2001) P2y(12), a new platelet ADP receptor, target of clopidogrel. Biochem Biophys Res Commun 283:379â383. https://doi.org/10.1006/bbrc.2001.4816
Schachter JB, Li Q, Boyer JL, Nicholas RA, Harden TK (1996) Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br J Pharmacol 118:167â173
Schachter JB, Boyer JL, Li Q, Nicholas RA, Harden TK (1997) Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C. Br J Pharmacol 122:1021â1024. https://doi.org/10.1038/sj.bjp.0701479
Scrivens M, Dickenson JM (2005) Functional expression of the P2Y14 receptor in murine T-lymphocytes. Br J Pharmacol 146:435â444. https://doi.org/10.1038/sj.bjp.0706322
Scrivens M, Dickenson JM (2006) Functional expression of the P2Y14 receptor in human neutrophils. Eur J Pharmacol 543:166â173. https://doi.org/10.1016/j.ejphar.2006.05.037
Skelton L, Cooper M, Murphy M, Platt A (2003) Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose. J Immunol 171:1941â1949
Sliwa M, Markovic D, Gabrusiewicz K, Synowitz M, Glass R, Zawadzka M, Wesolowska A, Kettenmann H, Kaminska B (2007) The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin a. Brain 130:476â489. https://doi.org/10.1093/brain/awl263
Sluyter R (2017) The P2X7 receptor. Adv Exp Med Biol â Protein Rev 19:17â53. https://doi.org/10.1007/5584_2017_59
Soulet C, Sauzeau V, Plantavid M, Herbert JM, Pacaud P, Payrastre B, Savi P (2004) Gi-dependent and -independent mechanisms downstream of the P2Y12 ADP-receptor. J Thromb Haemost 2:135â146
Soulet C, Hechler B, Gratacap MP, Plantavid M, Offermanns S, Gachet C, Payrastre B (2005) A differential role of the platelet ADP receptor P2Y1 and P2Y12 in Rac activation. J Thromb Haemost 3:2296â2306. https://doi.org/10.1111/j.1538-7836.2005.01588.x
Srinivas M, Calderon DP, Kronengold J, Verselis VK (2006) Regulation of connexin hemichannels by monovalent cations. J Gen Physiol 127:67â75. https://doi.org/10.1085/jgp.200509397
Stork PJ, Schmitt JM (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258â266
SupĆat-Wypych D, Dygas A, BaraĆska J (2010) 2âČ, 3âČ-O-(4-benzoylbenzoyl)-ATP-mediated calcium signaling in rat glioma C6 cells: role of the P2Y(2) nucleotide receptor. Purinergic Signal 6:317â325. https://doi.org/10.1007/s11302-010-9194-7
Sutherland EW (1972) Studies on the mechanism of hormone action. Science 177:401â408
Tas PW, Koschel K (1998) Sphingosine-1-phosphate induces a Ca2+ signal in primary rat astrocytes and a Ca2+ signal and shape changes in C6 rat glioma cells. J Neurosci Res 52:427â434. https://doi.org/10.1002/(SICI)1097-4547(19980515)52:4<427::AID-JNR6>3.0.CO;2-B
Tu MT, Luo SF, Wang CC, Chien CS, Chiu CT, Lin CC, Yang CM (2000) P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway. Br J Pharmacol 129:1481â1489. https://doi.org/10.1038/sj.bjp.0703182
van Corven EJ, Groenink A, Jalink K, Eichholtz T, Moolenaar WH (1989) Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 59:45â54
Van Kolen K, Slegers H (2004) P2Y12 receptor stimulation inhibits beta-adrenergic receptor-induced differentiation by reversing the cyclic AMP-dependent inhibition of protein kinase B. J Neurochem 89:442â453. https://doi.org/10.1111/j.1471-4159.2004.02339.x
Van Kolen K, Slegers H (2006a) Atypical PKCzeta is involved in RhoA-dependent mitogenic signaling by the P2Y(12) receptor in C6 cells. FEBS J 273:1843â1854. https://doi.org/10.1111/j.1742-4658.2006.05205.x
Van Kolen K, Slegers H (2006b) Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks. Purinergic Signal 2:451â469. https://doi.org/10.1007/s11302-006-9008-0
van Koppen C, Meyer zu Heringdorf D, Laser KT, Zhang C, Jakobs KH, Bunemann M, Pott L (1996) Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine-1-phosphate. J Biol Chem 271:2082â2087
Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJ (1997) cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89:73â82
Wan G, Zhou L, Lim QE, Wong YH, Too HP (2011) Cyclic AMP signalling through PKA but not Epac is essential for neurturin-induced biphasic ERK1/2 activation and neurite outgrowths through GFRalpha2 isoforms. Cell Signal 23:1727â1737. https://doi.org/10.1016/j.cellsig.2011.06.007
Wang L, Liu F, Adamo ML (2001) Cyclic AMP inhibits extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways by inhibiting Rap1. J Biol Chem 276:37242â37249. https://doi.org/10.1074/jbc.M105089200
Wang M, Kong Q, Gonzalez FA, Sun G, Erb L, Seye C, Weisman GA (2005) P2Y nucleotide receptor interaction with alpha integrin mediates astrocyte migration. J Neurochem 95:630â640. https://doi.org/10.1111/j.1471-4159.2005.03408.x
Webb TE, Feolde E, Vigne P, Neary JT, Runberg A, Frelin C, Barnard EA (1996) The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase. Br J Pharmacol 119:1385â1392
Weber G (2002) Reciprocal regulation: recognition of pattern of gene expression in cancer cells. Adv Enzym Regul 42:83â100
Wei W, Ryu JK, Choi HB, McLarnon JG (2008) Expression and function of the P2X(7) receptor in rat C6 glioma cells. Cancer Lett 260:79â87. https://doi.org/10.1016/j.canlet.2007.10.025
White N, Burnstock G (2006) P2 receptors and cancer. Trends Pharmacol Sci 27:211â217. https://doi.org/10.1016/j.tips.2006.02.004
Wildman SS, Unwin RJ, King BF (2003) Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions. Br J Pharmacol 140:1177â1186. https://doi.org/10.1038/sj.bjp.0705544
Wypych D, Pomorski P (2012) P2Y1 nucleotide receptor silencing and its effect on glioma C6 calcium signaling. Acta Biochim Pol 59:711â717. https://doi.org/10.18388/abp.2012_2115
Zhang FL, Luo L, Gustafson E, Palmer K, Qiao X, Fan X, Yang S, Laz TM, Bayne M, Monsma F Jr (2002) P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther 301:705â713
Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergâs Arch Pharmacol 362:299â309
Zwartkruis FJ, Bos JL (1999) Ras and Rap1: two highly related small GTPases with distinct function. Exp Cell Res 253:157â165. https://doi.org/10.1006/excr.1999.4695
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wypych, D., BaraĆska, J. (2020). Cross-Talk in Nucleotide Signaling in Glioma C6 Cells. In: BaraĆska, J. (eds) Glioma Signaling. Advances in Experimental Medicine and Biology, vol 1202. Springer, Cham. https://doi.org/10.1007/978-3-030-30651-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-30651-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30650-2
Online ISBN: 978-3-030-30651-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)